International Linked Clinical Trials (iLCT)
23 results.
Part three: What we’re doing to move lab discoveries into the clinic
In the past few weeks, VAI Voice has discussed what it takes to translate a promising laboratory discovery into a life-changing, approved treatment. In our…
Part two: Before a new medication can be used in patients, it must go through a gauntlet of tests to ensure it is safe and effective
In the second installment in our multi-part series on how a new medication moves from the lab to the doctor’s office, we take a look…
Evidence continues to mount that a newer class of anti-diabetic drugs called incretin mimetics, or glucagon-like peptide-1 receptor agonists, could slow…
HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…
Note: To read the commentary published in the Journal of Parkinson's Disease click here. Investigators will focus on safety for long-term use in non-cancer…
GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus…
Grand Rapids, Mich. (Sept. 23, 2014) – Van Andel Research Institute (VARI) has partnered with UK-based research charity The Cure Parkinson’s Trust on an initiative to…